Africa CDC Announces New Coronavirus Variant Emerges in Nigeria

 

Nigeria is back in the spotlight, after the confirmation of the state’s first virus case in February. A new variant of the coronavirus is supposed to have emerged in the sub-Saharan country. It could create panic as two recent variants from the UK and South Africa led to international travel restrictions and stricter lockdowns.

 

John Nkengasong, head of the Africa Centers for Disease Control and Prevention told reporters, “It’s a separate lineage from the U.K. and South Africa.” He added, “Give us some time…it’s still very early.”

 

The Associated Press saw a research paper which said that the variant in Nigeria was found in two patient samples: one collected on August 3 and the other on August 9, in Osun state.

 

“Over recent weeks, we’ve had a huge increase in number of samples to (Nigeria CDC) reference labs,” tweeted Chikwe Ihekweazu, the CDC director general. “This has led to an unusual delay with testing, but we’re working around the clock”. Many staff have cut short holidays and returned to work to deal with the crisis.

 

There are more than 80,000 confirmed infections in Nigeria. The Nigeria CDC said that December 17 saw the daily infections rise to 1,100 cases, with a “rapid increase” in past two weeks. The CDC attributed the rise to an increase in travel and “minimal compliance with COVID-19 safety measures.”

 

Once again, restrictions have been announced to curb the spread of the virus. These restrictions include limits on the number of people who can gather together as well as the closure of venues including bars and nightclubs.

 Photo Wikimedia

Source

BioNTech Could Make New Vaccine in 6 Weeks if Current Vaccine is Ineffective


Follow us on Google news for more updates and News










PLEASE READ THE IMPORTANT DISCLOSURES BELOW.

This content is being provided to you for informational purposes only. The content has been prepared by third parties not affiliated with CWEB Inc, a business. This content and any information contained therein, does not constitute a recommendation by CWEB to buy, sell or hold any security, financial product or instrument referenced in the content. This information neither is, nor should be construed as an offer, or a solicitation of an offer, to buy or sell securities by CWEB Inc. CWEB Inc. does not offer or provide any opinion regarding the nature, potential, value, suitability or profitability of any particular investment or investment strategy, and you shall be fully responsible for any investment decisions you make, and such decisions will be based solely on your evaluation of your financial circumstances, investment objectives, risk tolerance, and liquidity needs.

Unless stated otherwise, the web content provided by the CWEB family of companies is for educational purposes only. The information and tools provided neither are, nor should be construed, as an offer, or a solicitation of an offer, to buy or sell securities by CWEB Inc. or its affiliates. Unless stated otherwise, no information presented constitutes a recommendation by CWEB Inc. or its affiliates to buy, sell or hold any security, financial product or instrument discussed therein or to engage in any specific investment strategy.

Full Disclaimer

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.